{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:09:40Z","timestamp":1789200580492,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ahj.2017.09.010","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T03:01:23Z","timestamp":1505530883000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Mineralocorticoid receptor antagonists in patients with acute myocardial infarction \u2014 A systematic review and meta-analysis of randomized trials"],"prefix":"10.1016","volume":"195","author":[{"given":"Matthias","family":"Bossard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Binbraik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjit S.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2017.09.010_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/hrt.2010.215459","article-title":"Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction","volume":"97","author":"Kasama","year":"2011","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.ahj.2017.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/eurheartj\/ehq522","article-title":"Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction","volume":"32","author":"Solomon","year":"2011","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCOUTCOMES.111.964700","article-title":"Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010","volume":"5","author":"Smolina","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.ahj.2017.09.010_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2011.11.076","article-title":"Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia","volume":"167","author":"Beygui","year":"2013","journal-title":"Int J Cardiol"},{"issue":"34","key":"10.1016\/j.ahj.2017.09.010_bb0025","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2017.09.010_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ahj.2017.09.010_bb0035","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2017.09.010_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ahj.2005.03.032","article-title":"Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction","volume":"150","author":"Di Pasquale","year":"2005","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2017.09.010_bb0045","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2009.04.001","article-title":"Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?","volume":"157","author":"Weir","year":"2009","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2017.09.010_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00365510902802278","article-title":"Effects of aldosterone blockade on left ventricular function and clinical status during acute myocardial infarction","volume":"69","author":"Uzunhasan","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1755-5922.12006","article-title":"Does spironolactone have a dose-dependent effect on left ventricular remodeling in patients with preserved left ventricular function after an acute myocardial infarction?","volume":"31","author":"Vatankulu","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"16","key":"10.1016\/j.ahj.2017.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ahj.2017.09.010_bb0065","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"7414","key":"10.1016\/j.ahj.2017.09.010_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.09.010_bb0075","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.09.010_bb0080","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1016\/j.ahj.2017.09.010_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhj.2001.111258","article-title":"Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction","volume":"141","author":"Modena","year":"2001","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2017.09.010_bb0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MCA.0b013e32833fd243","article-title":"The effects of spironolactone on atrial remodeling in patients with preserved left ventricular function after an acute myocardial infarction: a randomized follow-up study","volume":"21","author":"Kayrak","year":"2010","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10.1016\/j.ahj.2017.09.010_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.01.009","article-title":"Effect of spironolactone on cardiac remodeling after acute myocardial infarction","volume":"4","author":"Wu","year":"2013","journal-title":"World J Emerg Med"},{"issue":"24","key":"10.1016\/j.ahj.2017.09.010_bb0100","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahj.2017.09.010_bb0105","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.106.668715","article-title":"Aldosterone and cardiovascular disease: smoke and fire","volume":"114","author":"Calhoun","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2017.09.010_bb0110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/eurjhf\/hfr129","article-title":"Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction","volume":"13","author":"Weir","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.ahj.2017.09.010_bb0115","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/eurheartj\/ehp555","article-title":"Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion","volume":"31","author":"Schmidt","year":"2010","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2017.09.010_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pharmthera.2013.11.006","article-title":"The cardioprotective effects of mineralocorticoid receptor antagonists","volume":"142","author":"van den Berg","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ahj.2017.09.010_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2017.09.010_bb0130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ahj.2017.09.010_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2005.06.010","article-title":"The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure","volume":"46","author":"Shah","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ahj.2017.09.010_bb0140","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2016.06.060","article-title":"Hyperkalemia in heart failure","volume":"68","author":"Sarwar","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/clc.4960290405","article-title":"Use and side-effect profile of spironolactone in a private cardiologist's practice","volume":"29","author":"Williams","year":"2006","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE.114.001104","article-title":"Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist","volume":"7","author":"Vardeny","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.ahj.2017.09.010_bb0155","doi-asserted-by":"crossref","first-page":"e0145958","DOI":"10.1371\/journal.pone.0145958","article-title":"Impact of aldosterone antagonists on sudden cardiac death prevention in heart failure and post\u2013myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Le","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ahj.2013.06.020","article-title":"Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG)","volume":"166","author":"Rao","year":"2013","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0165","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1016\/j.ijcard.2013.06.091","article-title":"Mineralocorticoid receptor antagonist use in eligible patients following acute myocardial infarction: real world data from the Acute Coronary Syndrome Israeli Surveys: 2004-2010","volume":"168","author":"Koifman","year":"2013","journal-title":"Int J Cardiol"},{"issue":"25","key":"10.1016\/j.ahj.2017.09.010_bb0170","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.010_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12872-015-0033-1","article-title":"Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"issue":"20","key":"10.1016\/j.ahj.2017.09.010_bb0180","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2017.09.010_bb0185","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjmed.2011.12.018","article-title":"Eplerenone is not superior to older and less expensive aldosterone antagonists","volume":"125","author":"Chatterjee","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2017.09.010_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.thromres.2016.04.027","article-title":"Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: a systematic review and meta-analysis of randomized controlled trials","volume":"144","author":"Elbers","year":"2016","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.ahj.2017.09.010_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1012754514127","article-title":"ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction","volume":"15","author":"Di Pasquale","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.ahj.2017.09.010_bb0200","first-page":"643","article-title":"Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study","volume":"125","author":"Rodriguez","year":"1997","journal-title":"Rev Med Chil"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:59:05Z","timestamp":1757570345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317302831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"alternative-id":["S0002870317302831"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.09.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor antagonists in patients with acute myocardial infarction \u2014 A systematic review and meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}